th a focus on infectious disease and hospital-acquired infections, HerpeSelect HSV serology, and a line of DxSelect IFA and ELISA products for testing for emerging infectious diseases. Focus Diagnostics maintains a distribution agreement with 3M Corporation to bring real-time polymerase chain reaction products to the market using Simplexa molecular chemistries and the 3M Integrated Cycler, a compact bench-top instrument. Celera Diagnostics offers molecular diagnostic products in segments, such as HIV-1 drug resistance testing (under the ViroSeq brand), reproductive genetics and transplantation (under the Atria and AlleleSeqr brands). Healthcare Information Technology The company provides interoperable technologies that help healthcare organizations and physicians enter, share, and access clinical information without costly information technology implementation or significant workflow disruption. The company’s Care360 EHR product allows physicians to generate a record of a clinical patient encounter, automates and streamlines the clinician's workflow, and allows for rapid deployment and implementation with minimal workflow disruption. The solution allows doctors to electronically create, manage and distribute patient encounter notes and allows for patient communication via a patient portal. It captures lab and radiology results, provides clinical decision support tools and allows doctors to send secure messages and clinical information to other practitioners and secure laboratory results to patients' personal health records. ChartMaxx is the company’s enterprise content management system for hospitals. Clients have contracted for its use at approximately 225 sites in North America to enable clinical and business workflows. Strategy The company’s five point strategy is: restore growth; drive operational excellence; simplify the organization; refocus on diagnostic information services; and deliver disciplined capital deployment. Regulations The company’s businesses are subject to or impacted by extensive and frequently changing laws and regulations in the United States (at both the federal and state levels) and the other jurisdictions in which it conducts business. These laws and regulations include regulations particular to its business, and laws and regulations relating to conducting business generally (e.g., export controls laws, U.S. Foreign Corrupt Practices Act and similar laws of other jurisdictions), including in the United States and in other jurisdictions. The company is required to comply with laws and regulations including the federal Health Insurance Portability and Accountability Act, as amended, and the regulations thereunder (collectively, ‘HIPAA’). Competition The company’s commercial clinical laboratory competitor is Laboratory Corporation of America Holdings, Inc. History Quest Diagnostics Incorporated was founded in 1967.
quest diagnostics inc
(DGX:New York Consolidated)
3 Giralda Farms
Madison, NJ 07940
|Hologic Inc||$34.40 USD||+0.39|
|Laboratory Corp of America Holdings||$119.19 USD||-0.58|
|QIAGEN NV||€21.79 EUR||-0.002|
|Roper Technologies Inc||$170.40 USD||+0.89|
|View Industry Companies|
Sponsored Financial Commentaries
To contact QUEST DIAGNOSTICS INC, please visit www.questdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.